Main FAQ Search Groups Members List Profile Private Messages
Log-in Register
 
Forum SIMSON JAWA ROMET (!!) Strona Główna
WuXi PharmaTech Well Positioned to Continue Growin

 
Napisz nowy temat   Odpowiedz do tematu    Forum SIMSON JAWA ROMET (!!) Strona Główna -> motocykle
Zobacz poprzedni temat :: Zobacz następny temat  
Autor Wiadomość
06nkrc57j8
hulajnoga



Dołączył: 24 Gru 2010
Posty: 35
Przeczytał: 0 tematów

Ostrzeżeń: 0/10
Skąd: England

PostWysłany: Czw 4:19, 27 Sty 2011    Temat postu: WuXi PharmaTech Well Positioned to Continue Growin

WuXi PharmaTech (Cayman) Inc. (NYSE: WX) announced today that its previously announced transaction with Charles River Laboratories International Inc. (NYSE: CRL) has been terminated by mutual agreement due to Charles River shareholder opposition. Under the terms of the termination agreement, WuXi will receive a breakup fee of $30 million.

"WuXi‘s strategy has not changed. Our goal is, and has long been,[link widoczny dla zalogowanych], to build a broad, integrated R&D service platform designed to help our customers improve the success of research and shorten the time of new product development," said Dr. Ge Li,[link widoczny dla zalogowanych], Chairman and Chief Executive Officer. "While we are disappointed that this transaction could not be completed, WuXi remains well positioned to meet our customers‘ needs and to continue to grow and expand as a standalone company.

"All of our businesses are performing very well," Dr. Li continued. "Each business unit has met or exceeded its targets for the second quarter,[link widoczny dla zalogowanych], and we recently increased our guidance for full-year 2010 financial performance.

"Virtually all of the large global pharmaceutical companies, as well as hundreds of smaller pharmaceutical and biotech companies and many leading medical device companies, are our customers," Dr. Li concluded. "We believe that strong trends for greater outsourcing and offshoring of R&D services will continue, and that WuXi, as the leading China-based contract research organization, is well positioned to benefit from this powerful outsourcing trend for many years to come."

Second Quarter Results

WuXi will report financial results for the second quarter ending June 30,[link widoczny dla zalogowanych], 2010,[link widoczny dla zalogowanych], on Monday, August 2, at 6:30 am EDT with a conference call at 8:30 am EDT to discuss the results and the outlook for WuXi‘s business. The conference call may be accessed by calling:

United States: 1-866-519-4004
China (Landline): 800-819-0121
China (Mobile): 400-620-8038
Hong Kong: 800-930-346
United Kingdom: 0-808-234-6646
International: +65-6723-9381
Conference ID: 90840146
Web PIN: 8656

A replay will be available two hours after the call‘s completion at:

United States: 1-866-214-5335
China North: 10-800-714-0386
China South: 10-800-140-0386
Hong Kong: 800-901-596
United Kingdom: 0-800-731-7846
International: +61-2-8235-5000
Passcode: 90840146

A live webcast of the conference call and replay will be available on the investor relations page of WuXi PharmaTech‘s website at .


Post został pochwalony 0 razy
Powrót do góry
Zobacz profil autora
Wyświetl posty z ostatnich:   
Napisz nowy temat   Odpowiedz do tematu    Forum SIMSON JAWA ROMET (!!) Strona Główna -> motocykle Wszystkie czasy w strefie EET (Europa)
Strona 1 z 1

 
Skocz do:  
Możesz pisać nowe tematy
Możesz odpowiadać w tematach
Nie możesz zmieniać swoich postów
Nie możesz usuwać swoich postów
Nie możesz głosować w ankietach


fora.pl - załóż własne forum dyskusyjne za darmo
xeon Template © Digital-Delusion
Powered by phpBB © 2001, 2002 phpBB Group
Regulamin